Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · LOTUSEYE

LOTUSEYE

HealthcareHealthcare Services₹211 cr market cap
₹102.25 ▲ +0.94% today As of 19 Nov 2026
52-week low ₹98.2252-week high ₹141.38

-28.3% from the 52-week high · +3.1% above the low

Lotus Eye Hospital & Institute Ltd. engages in the provision of eye care and related services. The company is headquartered in Coimbatore, Tamil Nadu. The company went IPO on 2008-07-11. The firm operates primarily in the field of ophthalmology (Eye) and its related operations. The company resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The firm provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The firm operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.

The short version. Promoter holding was 40.14% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

LOTUSEYE trades 28.3% below its 52-week high and 3.1% above its 52-week low.

Change over period: —

1M-8.0%
3M-12.3%
6M-7.3%
1Y-2.4%

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2020
Revenue7
Net profit0
Net margin %1.1
EPS (₹)0.04

4 · The owners

Who holds it, and are they adding?

Promoter holding40.14%

Unchanged over 8 quarters.

Domestic institutions0.02%

Down 0.02 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter40.1440.2240.3940.6340.6640.1440.1440.140.0
FII000.0100.010000
DII0.040.040.020.020.020.020.020.02-0.02
Public59.8259.7459.5859.3359.3159.8459.8559.85+0.03

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for LOTUSEYE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about LOTUSEYE

What is the LOTUSEYE share price?

LOTUSEYE (LOTUSEYE) last closed at ₹102.25, up 0.94% on the day. Its 52-week range is ₹98.22 to ₹141.38.

What is the market cap of LOTUSEYE?

LOTUSEYE has a market capitalisation of about ₹211 crore.

How are LOTUSEYE's latest results?

Promoter holding was 40.14% in Sep 2026, up 0.00 points over 8 quarters.

Who owns LOTUSEYE?

As of Sep 2026, shareholding was: Promoter 40.14%, DII 0.02%, Public 59.85%.

How many mutual funds hold LOTUSEYE?

0 mutual fund schemes held LOTUSEYE in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 18 Sep 2023 · Dividend - Rs. 0.5
  • 08 Sep 2022 · Dividend - Rs. 0.5
  • 08 Sep 2021 · Dividend - Rs. 0.5
  • 14 Sep 2018 · Dividend - Rs. 0.5
  • 02 Aug 2017 · Dividend - Rs. 0.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.